The purpose of this paper was to compare detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), in oropharynx/nares specimens collected using two different non-flocked swabs (M40 Transystem and BD ProbeTec Qx Collection Kit for Endocervical and Lesion Specimens) that were stored in phosphate buffered saline (PBS) to specimens collected using Aptima Multitest Kit swabs and stored in specimen transport media (STM).
Exploring alternative swabs for use in SARS-CoV-2 detection from the oropharynx and anterior nares.
Patriquin G, Davis I, Heinstein C, MacDonald J, Hatchette TF, LeBlanc JJ
Purpose
Conclusion
SARS-CoV-2 was detected in all three specimens from 13 of 15 patients (86.7%). In one patient, SARS-CoV-2 was not detected using either the reference (Aptima swab in STM) or the M40 swab but both genes amplified in the BD swab specimen stored in PBS. In another patient, neither gene amplified using the reference method (Aptima swab in STM) but the E-gene amplified in both the BD and M40 swab specimens stored in PBS.
Studies (1)
Purpose
The purpose of this study was to compare detection of SARS-CoV-2 in oropharynx/nares specimens collected using two different non-flocked swabs (M40 Transystem and BD ProbeTec Qx Collection Kit for Endocervical and Lesion Specimens) that were stored in PBS to specimens collected using Aptima Multitest Kit swabs stored in STM. Specimens were collected sequentially from the oropharynx/nares of fifteen patients previously diagnosed with SARS-CoV-2 (2-13 days post-diagnosis, median 2 days) using the M40 Transystem featuring a plastic shaft, the BD ProbeTec Qx Collection Kit for Endocervical and Lesion Specimens with a polyurethane tip, and the Aptima Multitest Kit (reference specimen). The M40 Transystem and the BD ProbeTec Qx endocervical swabs were placed in tubes containing PBS while the reference Aptima swab was placed in STM. All specimens were transported to the laboratory and processed in parallel within 4 h of collection or after 12 h at 4°C. SARS-CoV-2 was detected by the real-time RT-PCR based SARS-CoV-2 assay on the Cobas 6800 system. A positive result was defined as amplification of either the Orf1a or E gene.
Summary of Findings
The limit of detections for SARS-CoV-2 was <1 copy/mL, regardless of transport media (PBS or STM). For 13 of 15 patients (86.7%), SARS-CoV-2 was detected in all three swabs. In one patient, SARS-CoV-2 was not detected using either the reference (Aptima swab in STM) or the M40 swab but both genes amplified in the BD swab specimen stored in PBS. In another patient, neither gene amplified using the reference method (Aptima swab in STM) but the E-gene amplified in both the BD and M40 swab specimens stored in PBS.
Biospecimens
CellNasal cavityCellOral CavityPreservation Types
None (Fresh)Diagnoses
Pneumonia/Respiratory InfectionPlatforms
RNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Method of cell acquisition Aptima Multitest Kit swabBD ProbeTec Qx Collection Kit for Endocervical and Lesion Specimens with a polyurethane tipM40 Transystem featuring a plastic shaftStorage Short-term storage solution PBSSTMReal-time qRT-PCR Specific Targeted nucleic acid E-geneOrf1a